Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

ORLYNVAHTM is a novel oral penem antibiotic for the treatment of uUTIs. ORLYNVAHTM possesses potent activity against species of Enterobacterales including those that encode extended spectrum ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

As more people - and their respective pathogens - travel to space, it is likely that this is only the beginning.

However, infectious diseases that were hitherto under control are re-emerging globally and the pathogens of these diseases are highly resistant to known antibiotics.

You don’t need to “detox” your colon, but certain foods are known to naturally support colon health and function, reducing ...

Nosocomial infections caused by resistant Gram-positive organisms are on the rise, presumably due to a combination of factors including prolonged hospital exposure, increased use of invasive ...

While this topic will be a review to many, it is worth taking time to revisit it. Chemically water is not simple. It has ...

Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Nearly one in four infants lacks enough healthy gut bacteria essential for training their immune systems, putting them at ...